Search Within

Lisa Bodei

  1. "Springer"
Formats
  1. Journal Article (16)
  2. Book Section (15)
  3. Meeting Abstract (9)
  4. Guidelines (4)
  5. Editorial (2)
  6. Book Whole (1)
  7. Review (1)
Groups
  1. Molecular Imaging and Therapy Service (48)
  2. Radiology, Department of (48)
  3. Sloan Kettering Institute Postdocs (48)
  4. GSK Faculty (14)
  5. Center for Pancreatic Cancer Research (13)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (12)

More Groups

People
  1. Jason Lewis (12)
  2. Heiko Schoder (5)
  3. Simone Krebs (5)
  4. Neeta Pandit-Taskar (4)
  5. Steven Larson (4)
  6. Bradley Beattie (3)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (12)
  4. 2022 (3)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. European Journal of Nuclear Medicine and Molecular Imaging (26)
  2. Radiopharmaceutical Therapy (9)
  3. Annals of Surgical Oncology (2)
  4. Clinical and Translational Imaging (2)
  5. Nuclear Oncology: From Pathophysiology to Clinical Applications. 2nd ed (2)
  6. Nuclear Oncology: From Pathophysiology to Clinical Applications. 3rd ed (2)

More Publications

Publishers
  1. Springer (48)

Results (48)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
    Guidelines

    Weber, M.; Lam, M.; Chiesa, C.; Konijnenberg, M.; Cremonesi, M.; Flamen, P.; Gnesin, S.; Bodei, L.; Kracmerova, T.; Luster, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2022)

    Fulltext@MSK | Save
  • The phase 3 NETTER-1 study of [(177)Lu-]Lu-DOTA-TATE in patients with midgut neuroendocrine tumours: Final overall survival and long-term renal safety
    Meeting Abstract

    Kunz, P.; Caplin, M. E.; Ruszniewski, P. B.; Bodei, L.; Hendifar, A.; Mittra, E.; Wolin, E. M.; Yao, J. C.; Pavel, M. E.; Grande, E.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: Implications for patient management
    Review

    Roll, W.; Weckesser, M.; Seifert, R.; Bodei, L.; Rahbar, K.
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • Early identification of residual disease after neuroendocrine tumor resection using a liquid biopsy multigenomic mRNA signature (NETest)
    Journal Article

    Modlin, I. M.; Kidd, M.; Oberg, K.; Falconi, M.; Filosso, P. L.; Frilling, A.; Malczewska, A.; Salem, R.; Toumpanakis, C.; Laskaratos, F. M.; more...
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors
    Journal Article

    Nicolini, S.; Bodei, L.; Bongiovanni, A.; Sansovini, M.; Grassi, I.; Ibrahim, T.; Monti, M.; Caroli, P.; Sarnelli, A.; Diano, D.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals
    Journal Article

    Kalidindi, T. M.; Lee, S. G.; Jou, K.; Chakraborty, G.; Skafida, M.; Tagawa, S. T.; Bander, N. H.; Schoder, H.; Bodei, L.; Pandit-Taskar, N.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • Comparison of (68)Ga-DOTA-JR11 PET/CT with dosimetric (177)Lu-satoreotide tetraxetan ((177)Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
    Journal Article

    Krebs, S.; O'Donoghue, J. A.; Biegel, E.; Beattie, B. J.; Reidy, D.; Lyashchenko, S. K.; Lewis, J. S.; Bodei, L.; Weber, W. A.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2020)

    Fulltext@MSK | Save
  • Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with (177)Lu-Dotatate: An analysis of the NETTER-1 study
    Journal Article

    Strosberg, J.; Kunz, P. L.; Hendifar, A.; Yao, J.; Bushnell, D.; Kulke, M. H.; Baum, R. P.; Caplin, M.; Ruszniewski, P.; Delpassand, E.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2020)

    Fulltext@MSK | Save
  • A metastatic tumor is no different to a viral pandemic: Lessons learnt from COVID-19 may teach us to change the PRRT paradigm
    Editorial

    Paganelli, G.; Bodei, L.; Modlin, I.
    European Journal of Nuclear Medicine and Molecular Imaging (2020)

    Fulltext@MSK | Save
  • Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: A need for standardised practice
    Journal Article

    Prasad, V.; Srirajaskanthan, R.; Toumpanakis, C.; Grana, C. M.; Baldari, S.; Shah, T.; Lamarca, A.; Courbon, F.; Scheidhauer, K.; Baudin, E.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2020)

    Fulltext@MSK | Save